Closed Loop Auditory Stimulus in Sleep and epilepsY (CLASSY)

December 10, 2021 updated by: Cardiff and Vale University Health Board
This is a single-centre pilot study of a non-invasive auditory stimulation during sleep in participants with temporal lobe epilepsy.

Study Overview

Status

Completed

Detailed Description

The primary objectives will be to pilot the use of home-based auditory stimulation during sleep in 10-20 participants with temporal lobe epilepsy using wireless devices.

Study Type

Interventional

Enrollment (Actual)

17

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cardiff, United Kingdom, CF14 4XW
        • Cardiff and Vale UHW, Neurology department, ward C4, video-EEG monitoring unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Participant is willing and able to give informed consent
  2. Participant diagnosed with temporal lobe epilepsy
  3. Will have had fewer than three generalized tonic clonic seizures per month in the last three months
  4. Will be taking 3 or fewer anti-seizure medications.
  5. Will have access to a computer or cellphone with an internet connection

Exclusion Criteria:

  1. Abnormal hearing that cannot be corrected to normal overnight.
  2. Abnormal vision that cannot be corrected to normal during the day.
  3. Unwilling to abstain from caffeine, alcohol, daytime naps and extreme physical exercise in the 12 hours prior to the study.
  4. Cannot read English
  5. Engaged in night work in the previous 2 months
  6. Any history of seizures triggered by music or sounds
  7. Travelled across more than 2 time zones in the last 2 months
  8. Prescribed/taking sleeping tablets other than clobazam
  9. Cannabis use >4 joints/day.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Stim First
Participants slept for one night while auditory sounds were played at specific points during slow wave sleep. At least one week later, an identical procedure occured with no acoustic sounds.
50ms of low volume pink noise delivered during slow wave sleep
Sham Comparator: Sham First
Participants slept for one night while no acoustic sounds were played. At least one week later, an identical procedure occured while acoustic sounds were played at specific points during slow wave sleep.
50ms of low volume pink noise delivered during slow wave sleep

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in EEG waveform amplitude
Time Frame: 5 seconds after stimulus
Does the acoustic sound delivery alter EEG waveform amplitude of slow wave sleep
5 seconds after stimulus
Change in Serial Reaction Time Task memory test
Time Frame: Baseline and following day
Does the delivery of acoustic sounds alter post-sleep preformance on the above task
Baseline and following day
Change in Paired Associates Learning memory test
Time Frame: Baseline and following day
Does the delivery of acoustic sounds alter post-sleep preformance on the above task
Baseline and following day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Khalid Hamandi, MRCP/Phd, University Hospital of Wales/Cardiff University
  • Principal Investigator: Jennifer Roebber, PhD, University Hospital of Wales/Cardiff University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

August 31, 2021

Study Completion (Actual)

August 31, 2021

Study Registration Dates

First Submitted

November 25, 2021

First Submitted That Met QC Criteria

December 10, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

December 16, 2021

Last Update Submitted That Met QC Criteria

December 10, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Anonymous sleeping-EEG and behavior scores can be shared with researchers.

IPD Sharing Time Frame

Behavior tasks are available on Gitlab as a repository and can be shared on request

IPD Sharing Supporting Information Type

  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Temporal Lobe Epilepsy

Clinical Trials on Closed loop auditory stimulus

Subscribe